Physician

Amandeep Singh Dhaliwal, M.D.

According to 2025 Medicare claims, Amandeep Dhaliwal, M.D. (NPI: 1982921128) practices interventional cardiology in the Cedar Rapids, IA market, with the plurality of this provider's patient population coming from Linn, IA. This provider's primary affiliated billing organization is MERCY MEDICAL CENTER (NPI: 1669617106; TIN: 420698295) and primary practice location at 52403-1251. Dhaliwal is affiliated with the Mercycare Accountable Care Organization, LLC (ACO ID: A4649), UnityPoint Accountable Care, L.C. (ACO ID: A5170), Aledade 155 National MSSP (ACO ID: A5358), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Dhaliwal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 3,179 traditional Medicare patients, billed 6,707 HCPCS/CPT codes, and received $208,994 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 10,187 prescription claims across 1,108 beneficiaries totaling $1,823,702 in drug costs, led by Eliquis (Apixaban). 2021 DME data shows 24 claims. Open Payments data shows 27 records totaling $524. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $63,705 to $1,823,702. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,329	5,346	$205,500
2016	2,422	5,336	$206,560
2017	2,436	5,810	$222,964
2018	2,250	5,499	$239,443
2019	2,955	6,720	$227,889
2020	2,771	6,137	$198,334
2021	3,167	6,353	$179,264
2022	3,044	6,814	$237,699
2023	2,800	5,866	$223,222
2024	3,179	6,707	$208,994

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	249	1,137	$63,705
2016	351	2,219	$155,667
2017	448	3,079	$292,232
2018	580	4,298	$488,654
2019	685	5,548	$692,868
2020	792	6,855	$984,003
2021	769	6,860	$1,163,058
2022	867	8,194	$1,502,853
2023	985	9,270	$1,778,445
2024	1,108	10,187	$1,823,702

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	24	$1,450
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	566	895	$83
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	340	342	$47
93018	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician	156	156	$10
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	443	473	$9
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	2,326	3,354	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	776	46,587	$887,866
Xarelto	Rivaroxaban	251	14,838	$270,517
Entresto	Sacubitril/Valsartan	152	9,452	$210,911
Repatha Sureclick	Evolocumab	134	4,872	$95,190
Brilinta	Ticagrelor	70	4,514	$65,633

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	27	$524	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Amandeep Singh Dhaliwal, M.D.?

Tedicare shows public-source Medicare data for Amandeep Singh Dhaliwal, M.D. (NPI 1982921128), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amandeep Singh Dhaliwal, M.D. have ACO affiliation data?

Amandeep Singh Dhaliwal, M.D. is shown with ACO affiliation data for Mercycare Accountable Care Organization, LLC (MSSP, ACO ID A4649), UnityPoint Accountable Care, L.C. (MSSP, ACO ID A5170), Aledade 155 National MSSP (MSSP, ACO ID A5358), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Amandeep Singh Dhaliwal, M.D.?

Amandeep Singh Dhaliwal, M.D. is linked to MERCY MEDICAL CENTER (billing NPI 1669617106) in the available physician profile data.

Does Amandeep Singh Dhaliwal, M.D. have Open Payments data?

Amandeep Singh Dhaliwal, M.D. has 27 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.